Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher P Austin

Showing results (151-160 of 220) with videos related to

Pageof 22
Sort By:
Bioorganic & Medicinal Chemistry Letters|October 20, 2009
Evaluation of substituted 6-arylquinazolin-4-amines as potent and selective inhibitors of cdc2-like kinases (Clk)Bryan T Mott, Cordelle Tanega, Min Shen, et al.
Chemical Research in Toxicology|July 31, 2013
Systematic study of mitochondrial toxicity of environmental chemicals using quantitative high throughput screeningMatias S Attene-Ramos, Ruili Huang, Srilatha Sakamuru, et al.
Nature Reviews. Drug Discovery|December 15, 2019
Therapies for rare diseases: therapeutic modalities, progress and challenges aheadErik Tambuyzer, Benjamin Vandendriessche, Christopher P Austin, et al.
Methods in Enzymology|November 18, 2006
Fluorescent protein-based cellular assays analyzed by laser-scanning microplate cytometry in 1536-well plate formatDouglas S Auld, Ronald L Johnson, Ya-qin Zhang, et al.
European Journal of Human Genetics : EJHG|November 22, 2017
The International Rare Diseases Research Consortium: Policies and Guidelines to maximize impactHanns Lochmüller, Josep Torrent I Farnell, Yann Le Cam, et al.
Bioorganic & Medicinal Chemistry|June 23, 2009
Quantitative high-throughput screening identifies inhibitors of anthrax-induced cell deathPing Jun Zhu, John P Hobson, Noel Southall, et al.
Journal of Biomolecular Screening|June 8, 2014
Niemann-Pick Disease Type C: Induced Pluripotent Stem Cell-Derived Neuronal Cells for Modeling Neural Disease and Evaluating Drug EfficacyDaozhan Yu, Manju Swaroop, Mengqiao Wang, et al.
Science (New York, N.Y.)|August 6, 2011
Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targetsJing Yuan, Ken Chih-Chien Cheng, Ronald L Johnson, et al.
Journal of Medicinal Chemistry|January 22, 2011
Evaluation of quinazoline analogues as glucocerebrosidase inhibitors with chaperone activityJuan J Marugan, Wei Zheng, Omid Motabar, et al.
Environmental Health Perspectives|May 6, 2011
Chemical genomics profiling of environmental chemical modulation of human nuclear receptorsRuili Huang, Menghang Xia, Ming-Hsuang Cho, et al.
Pageof 22

Showing results (151-160 of 220) with videos related to

Sort By:
Pageof 22
Bioorganic & Medicinal Chemistry Letters|October 20, 2009
Evaluation of substituted 6-arylquinazolin-4-amines as potent and selective inhibitors of cdc2-like kinases (Clk)Bryan T Mott, Cordelle Tanega, Min Shen, et al.
Chemical Research in Toxicology|July 31, 2013
Systematic study of mitochondrial toxicity of environmental chemicals using quantitative high throughput screeningMatias S Attene-Ramos, Ruili Huang, Srilatha Sakamuru, et al.
Nature Reviews. Drug Discovery|December 15, 2019
Therapies for rare diseases: therapeutic modalities, progress and challenges aheadErik Tambuyzer, Benjamin Vandendriessche, Christopher P Austin, et al.
Methods in Enzymology|November 18, 2006
Fluorescent protein-based cellular assays analyzed by laser-scanning microplate cytometry in 1536-well plate formatDouglas S Auld, Ronald L Johnson, Ya-qin Zhang, et al.
European Journal of Human Genetics : EJHG|November 22, 2017
The International Rare Diseases Research Consortium: Policies and Guidelines to maximize impactHanns Lochmüller, Josep Torrent I Farnell, Yann Le Cam, et al.
Bioorganic & Medicinal Chemistry|June 23, 2009
Quantitative high-throughput screening identifies inhibitors of anthrax-induced cell deathPing Jun Zhu, John P Hobson, Noel Southall, et al.
Journal of Biomolecular Screening|June 8, 2014
Niemann-Pick Disease Type C: Induced Pluripotent Stem Cell-Derived Neuronal Cells for Modeling Neural Disease and Evaluating Drug EfficacyDaozhan Yu, Manju Swaroop, Mengqiao Wang, et al.
Science (New York, N.Y.)|August 6, 2011
Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targetsJing Yuan, Ken Chih-Chien Cheng, Ronald L Johnson, et al.
Journal of Medicinal Chemistry|January 22, 2011
Evaluation of quinazoline analogues as glucocerebrosidase inhibitors with chaperone activityJuan J Marugan, Wei Zheng, Omid Motabar, et al.
Environmental Health Perspectives|May 6, 2011
Chemical genomics profiling of environmental chemical modulation of human nuclear receptorsRuili Huang, Menghang Xia, Ming-Hsuang Cho, et al.
Pageof 22